Story perspectives

AstraZeneca Invests £300 M, Creates 1,000 Jobs Post UK-US Trade Deal

4/30/2026

Summary

Story summary

AstraZeneca will invest £300 million in Cambridge and Macclesfield facilities after Prime Minister Keir Starmer and President Donald Trump negotiated a U.S.–U.K. trade agreement.
It will secure about 1,000 jobs.
Prime Minister Keir Starmer said the funding shows confidence in Labour’s economic plan.
Chief Executive Pascal Soriot said the deal will raise NHS drug spending and improve access.
It follows the £450 million Liverpool vaccine plant cancellation and £200 million Cambridge expansion pause.

History

Historical Context

After the 2009 Life Sciences Blueprint set a national agenda, the 2011 Strategy for UK Life Sciences formalised government-industry deals, and AstraZeneca pledged a $500 million Cambridge R&D campus in 2013. Building on these policies, the 2021 Life Sciences Vision targets making the UK the world’s leading life-science hub by 2031, underpinning today’s UK-US partnership and new AstraZeneca expansion.

1 of 2

Story summary

AstraZeneca will invest £300 million in Cambridge and Macclesfield facilities after Prime Minister Keir Starmer and President Donald Trump negotiated a U.S.–U.K. trade agreement.
It will secure about 1,000 jobs.
Prime Minister Keir Starmer said the funding shows confidence in Labour’s economic plan.
Chief Executive Pascal Soriot said the deal will raise NHS drug spending and improve access.
It follows the £450 million Liverpool vaccine plant cancellation and £200 million Cambridge expansion pause.

1 / 2